This is a copy from an email I received from Steve Kroening (his newsletter Volume 4, Issue 49, June 23, 2014).
Since chromium is a key mineral that helps with insulin metabolism, most diabetics are familiar with it. Unfortunately, chromium doesn't help every diabetic. So I've written about ways to make chromium work even better in your battle against diabetes. One of those ways is to take the nutrient with your anti-diabetes drugs. But new research suggests there's another nutrient you can take with chromium and your medications that will help them all work even better.
In the randomized, double-blind, controlled study, researchers followed 447 type-2 diabetic patients. They divided the patients into two groups. They gave one group chromium picolinate (600 mcg chromium daily) with biotin (2 mg daily). The patients also continued their oral anti-diabetic drugs. Then the researchers compared how well this group did to a second group taking placebo supplements.
Here's what they found. The patients taking the chromium and biotin supplements saw a dramatic improvement in their Hgb A1c. This is an extremely important marker for long-term glucose levels. And those with the worst Hgb A1c at outset (greater than 10%) had the best improvement with the two supplements. Their Hgb A1c came down by 1.76%.
But that's not all. The patients taking the chromium and biotin saw their fasting glucose fall an average of nearly 10 points. And, again, the worse their levels were at outset, the better they fared. Their fasting glucose dropped a whopping 35.8 mg/dL. And they didn't experience any significant adverse effects.
If you have type-2 diabetes (or type-1) and you're taking anti-diabetic medications, consider taking chromium and biotin together with your medication. You might see much better control of your glucose with these two nutrients. You can take the same dosages used in this study.
Albarracin, C.A., B.C. Fuqua, et al. “Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type-2 diabetes,” Diabetes Metab Res Rev, 2008; 24(1): 41-51.
Next Discussion: oral medications »